TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Onconetix ( (ONCO) ) has provided an update.
On May 30, 2025, Onconetix, Inc. held a special meeting of stockholders where two key proposals were approved. The first was an amendment to the company’s Certificate of Incorporation to allow a reverse stock split at a ratio between 1-for-10 and 1-for-150, to be determined by the Board. The second was the approval to adjourn the meeting if necessary to gather more proxies for the reverse stock split proposal. Both proposals received sufficient votes for approval.
Spark’s Take on ONCO Stock
According to Spark, TipRanks’ AI Analyst, ONCO is a Underperform.
Onconetix’s overall score reflects substantial financial difficulties with significant operating losses and negative profitability metrics. The technical analysis suggests a bearish trend, and the valuation metrics are unfavorable due to negative earnings. These factors combine to give the stock a low attractiveness score.
To see Spark’s full report on ONCO stock, click here.
More about Onconetix
Average Trading Volume: 22,303,012
Technical Sentiment Signal: Sell
Current Market Cap: $3.37M
For detailed information about ONCO stock, go to TipRanks’ Stock Analysis page.